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We have developed a total RNA amplification and labeling strategy for use with Affymetrix GeneChips. Our protocol, which we denote BIIB,
employs two rounds of linear T7 amplification followed by Klenow labeling to generate a biotinylated cDNA. In benchmarking studies using a
titration of mouse universal total RNA, BIIB outperformed commercially available kits in terms of sensitivity, accuracy, and amplified target
length, while providing equivalent results for technical reproducibility. BIIB maintained 50 and 44% present calls from 100 and 50 pg of total
RNA, respectively. Inter- and intrasample precision studies indicated that BIIB produces an unbiased and complete expression profile within a
range of 5 ng to 50 pg of starting total RNA. From a panel of spiked exogenous transcripts, we established the BIIB linear detection limit to be 20
absolute copies. Additionally, we demonstrate that BIIB is sensitive enough to detect the stochastic events inherent in a highly diluted sample.
Using RNA isolated from whole tissues, we further validated BIIB accuracy and precision by comparison of 224 expression ratios generated by
quantitative real-time PCR. The utility of our method is ultimately illustrated by the detection of biologically expected trends in a T cell/B cell
titration of 100 primary cells flow sorted from a healthy mouse spleen.
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sample; Laser capture microdissectionLess than 5 years ago, application of gene expression pro-
filing was restricted to biological systems that yielded mic-
rogram quantities of total RNA. Exploratory research projects
utilizing emerging laboratory technologies, such as laser cap-
ture microdissection (LCM) and cell flow sorting, were sig-
nificantly compromised or altogether infeasible. Likewise,
translational medicine studies were constrained due to difficul-
ties in obtaining adequate amounts of RNA from precious
clinical samples. Various RNA amplification schemes have
recently emerged that released the scientific community from
these sample size limitations. Typically, these protocols in-
volve PCR-based exponential amplification, single or multi-
ple rounds of linear amplification, or a combination of both
methods [1,2].⁎ Corresponding authors. Fax: +1 617 679 3208.
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doi:10.1016/j.ygeno.2006.03.004PCR-based amplification methods are significantly faster,
less laborious, and more cost effective and hold the potential of
starting from smaller amounts of total RNA. Indeed, novel
biological insights have been elucidated from transcriptional
profiles using geometric amplification from single neuronal
progenitor cells [3]. However, studies investigating product
fidelity reveal that methods of this type often distort transcript
stoichiometry [2,4–7]. These observations are consistent with
theoretical considerations that suggest the exponential nature of
PCR could introduce sequence-, length-, and abundance-
dependent biases into the transcript pool.
T7-polymerase-based linear amplification has been widely
adopted as the method of choice in the profiling community,
since it accurately retains the transcript stoichiometry of the
original sample [8–11]. A pitfall of this method is 3′ truncation
of the amplified target, but this is generally considered accept-
able when using microarrays containing probe sets that are
similarly biased. A more significant drawback is that even the
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of total RNA [11–14]. While these more recent methods
demonstrate 3-log improvement over traditional expression pro-
filing sample requirements, a considerable demand still exists for
a procedure that works reliably from picogram quantities of
material.
We have developed an amplification and labeling strategy for
Affymetrix (Santa Clara, CA, USA) GeneChips that reduces the
total RNA requirement by an additional 1 to 2 logs. Our pro-
tocol, which we denote BIIB, uses two rounds of linear T7
amplification followed by Klenow labeling to generate a bio-
tinylated cDNA. First, we benchmark our process against the
commercially available NuGEN Ovation Biotin System (NGN),
Arcturus RiboAmp HS (ARC HS), and Affymetrix One Cycle
(AFFX 1rd) and Two Cycle (AFFX 2rd) labeling kits through
measurement of target yield, present calls, target degradation,
accuracy of exogenous control RNA, and expression intensity
correlation. Next, we establish inter- and intrasample precision
of BIIB as a function of starting material and demonstrate pre-
servation of transcript abundance relationships across the titra-
tion. We also establish accuracy and linear limit of detection
estimates using exogenous transcript spikes. From separate
experiments involving RNA isolated from whole tissues, we
further validate BIIB accuracy by comparison of 224 expression
ratios using quantitative real-time PCR (QRT-PCR). Finally, we
demonstrate the utility of this method in a Tcell/B cell titration of
100 primary cells flow sorted from a healthy mouse spleen.
Results
Benchmarking to commercial amplification protocols
We evaluated three commercial amplification kits, AFFX
2rd, NGN, and ARCHS, as well as developing our own process,
BIIB. To benchmark BIIB against these kits, we used each
commercial protocol on duplicate samples of 500 ng, 50 ng,
5 ng, 0.5 ng, and 50 pg total RNA, diluted serially from a mouse
universal stock solution. Similarly, we conducted BIIB on
quadruplicates of 5-ng, 1-ng, 0.5-ng, 100-pg, 50-pg, and 10-pg
dilutions. These titrations were chosen because preliminary
experiments indicated this as the appropriate working range. We
also labeled and hybridized quadruplicates of 1 μg of total RNA
diluted from the mouse universal stock using AFFX 1rd; this
served as a basis of comparison for our analysis. All targets were
hybridized to Affymetrix MG-430A GeneChips, representing
more than 22,000 transcriptional elements. We used five criteria
to assess the performance of each method: yield of amplified
material, present call percentage, target degradation plots, exo-
genous spike accuracy, and R2 values between replicates.
Yield data, which are typically represented in total mass of
target created, were converted to reflect the number of chips that
could be hybridized from the amplified material, since methods
that generate a cDNA target need only 2 μg for hybridization,
while 11 μg of cRNA target is required for equivalent perform-
ance (Fig. 1A). At 5 ng of total RNA, BIIB yields enough cRNA
to label and hybridize 38 GeneChips, compared to AFFX 2rd,
ARC HS, and AFFX 1rd, at nearly 7 each, and NGN at only 1.Furthermore, BIIB produced enough material for hybridization
with as little as 10 pg of total RNA, at least a 50-fold improve-
ment over all commercial kits.
Next, we evaluated the percentage of probe sets designated as
present, a commonly used GeneChip indicator of overall assay
performance (Fig. 1B). Notably, BIIB generated greater than
40% present calls starting from only 50 pg of total RNA. In
comparison, all other commercial protocols required 5 ng to
achieve this mark. These data provided an initial indication that
BIIB could reduce total RNA requirements by almost 2 logs.
Typically, the 3′ bias is determined using a ratio of expression
intensities from probe sets designed to the 3′ and 5′ end (3′/5′
ratio) of a housekeeping transcript. In lieu of this analysis, which
is limited to only a handful of transcript sequences, we used the
AffyRNAdeg function of the Bioconductor Affy module for a
comprehensive analysis of truncation tendencies [15,16]. In
brief, AffyRNAdeg orders the perfect match intensity for
individual probes in a probe set by location relative to the 5′
end of the targeted RNA molecule. The raw intensity for each
probe location is then averaged across all probe sets. Target
degradation plots were generated for AFFX 1rd data or for all
amplification strategies using data at 5 ng of total RNA (Fig.
1C). On average, the 5′ probe shows a 12, 19, 25, 25, and 34%
reduction from the maximum 3′ probe intensity for AFFX 1rd,
BIIB, AFFX 2rd, NGN, and ARC HS, respectively. By this
criterion, BIIB outperformed other commercial amplification
protocols, but could not equal the extended transcript length in
the AFFX 1rd protocol. This is consistent with previous studies
that have shown that compounding 3′ bias effects are introduced
during successive rounds of amplification [9,11,12,14]. Inter-
estingly, the magnitude of the truncation bias seen in target
degradation plots correlates directly with the differences in pre-
sent call percentage for each protocol (Fig. 1B), clearly illus-
trating the importance of target length in generating robust
expression profiles.
Accuracy of each protocol was determined using the exo-
genous RNA transcript spikes. Fifteen, 4, 2, and 1 fg of Bacillus
subtilis transcripts dap, thr, phe, and lys, respectively, were
contained within each 5-ng sample of total RNA. Similarly, the
spikes were represented at 3, 0.8, 0.4, and 0.2 pg within the
AFFX 1rd sample. A linear regression of expression intensity
versus mass of the spike was plotted (Fig. 1D). Based on both
slope and R2 values, BIIB shows superior performance, coming
closest to achieving the ideal values of 1, compared to all other
amplification protocols. Remarkably, BIIB also demonstrated
accuracy values equal to those of AFFX 1rd.
Finally, within-method reproducibility was measured by
calculating R2 values from pair-wise comparisons, for probe
sets called present, using replicate data at 5 ng of total RNA
(see Supplementary Table 1). A probe set was used in the
analysis if 50% of the replicates reported it as present. AFFX
1rd, BIIB, AFFX 2rd, NGN, and ARC HS had R2 values of
0.97, 0.92, 0.95, 0.86, and 0.80, respectively. Consistent with
other reports, our data suggest that technical reproducibility is
compromised when using significantly reduced input RNA
[6,11]. However, this phenomenon is minimized when using
the AFFX 2rd or BIIB protocols. Overall, BIIB outperformed
Fig. 1. Benchmarking to commercial amplification protocols using mouse universal total RNA. For all graphs, the dotted line represents average replicate values from
1 μg total RNA using AFFX 1rd. Data for BIIB (red diamond), AFFX 2rd (orange square), ARC HS (green circle), and NGN (blue triangle) are presented as average
values of all replicates. Error bars are included for BIIB data where n = 4, otherwise n = 2. BIIB shows equivalent or superior performance in all benchmarking criteria
compared to other amplification protocols. (A) Number of Affymetrix GeneChips that can be hybridized from amplified product as a function of total RNA starting
mass. The y axis has been normalized since amplification methods that generate a cDNA target need only 2 μg for hybridization, while 11 μg of cRNA target is
required for equivalent performance. (B) Percentage of probe sets called present as a function of total RNA starting mass. (C) Target degradation plots for 5 ng of total
RNA using the AffyRNAdeg function of the Bioconductor Affy module. The average intensity for all probe locations is presented for each amplification protocol. The
slope of each line is linked directly to the severity of truncation and thus inversely proportional to the average target length. (D) Accuracy of exogenous RNA spikes for
5 ng of total RNA sample. 15, 4, 2, and 1 fg of Bacillus subtilis transcripts dap, thr, phe, and lys, respectively, was added to 5 ng of total RNA. A linear regression of
expression intensity versus mass of the spike would ideally produce a slope and R2 value of 1.
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length, and total RNA requirements for adequate present calls,
while providing equivalent results for technical reproducibility
measurements. A summary of these benchmarks, as well as
cost, processing time, and workload considerations, is com-
piled in Supplementary Table 2.
Precision of BIIB
To establish formally the technological limits of BIIB, such as
precision, accuracy, and sensitivity, a detailed analysis for the
data set presented above was undertaken. Intrasample precision
is defined as the reproducibility of probe set intensity across
replicates of a single starting total RNA mass. Intersample
precision is defined as the reproducibility of probe set intensity
across a range of starting total RNA mass. A qualitative sum-
mary of the overall precision is illustrated using a heat map of
expression intensity for all probe sets and samples (Fig. 2).
Intrasample precision appeared consistent from 5 ng to 100 pg of
starting material, with distinct variability being introduced intothe replicate data at 50 and 10 pg. Intersample precision is
roughly maintained across all starting masses, although the
number of high- and mid-expressing genes is slightly reduced at
50 pg and substantially reduced when starting with 10 pg of total
RNA. This trend is more obvious in a related heat map in which
the expression intensities of replicate samples have been
averaged (see Supplementary Fig. 1). These intra- and inter-
sample tendencies are also supported by calculation of pair-wise
Pearson correlation coefficients for all sample combinations (see
Supplementary Fig. 2 and Supplementary Table 3).
Intrasample precision was quantitatively determined by
calculating the coefficient of variation (CV), a measurement of
the standard deviation relative to average expression intensity,
for each probe set across replicate hybridizations at each mass of
total RNA (Fig. 3A). For 5, 1, and 0.5 ng of total RNA, BIIB had
consistent intrasample precision characteristics and the CV of
these samples was slightly greater than the CVof AFFX 1rd at
equivalent average intensities. This difference in variability bet-
ween the two protocols could be attributed to the additional
sample processing steps of BIIB, probe/target affinity properties
Fig. 2. BIIB global precision. Four replicate samples starting from 5 ng, 1 ng,
0.5 ng, 100 pg, 50 pg, or 10 pg of mouse universal total RNA were processed
using BIIB. Probe set rows were ordered by descending average intensity of all
samples and then globally false colored based on all expression values. Red,
yellow, and black represent high (log2 RFU = 16), mid (log2 RFU = 12), and low
(log2 RFU = 8) gene expression intensity, respectively.
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BIIB protocol. At the GeneChip normalization target intensity
value of 3.4 (2500 RFU), BIIB had a CV of about 3.5% using
5 ng, 1 ng, or 500 pg of starting material, compared to 1.3% forFig. 3. BIIB intrasample and intersample precision. (A) Intrasample precision.
The coefficient of variation and average expression intensity for each probe set
were calculated across replicate hybridizations (n = 4) starting from 5 ng, 1 ng,
0.5 ng, 100 pg, 50 pg, or 10 pg of mouse universal total RNA (black traces,
lower left to upper right, respectively). The same analysis was conducted using
four replicate hybridizations from 1 μg of mouse universal total RNA using
AFFX 1rd (gray trace). Dashed vertical lines represent the approximate
expression intensities of exogenous spikes dap, thr, phe, and lys in each sample.
(B) Stochastic effects of dilution. The coefficient of variation for each
exogenous spike present between 1000 and 8 copies, for starting total RNA
mass at and below 500 pg, was plotted as a function of copy number (triangles).
The theoretical deviation due to the stochastic variance inherent in working with
highly diluted samples of limiting material can be estimated by a Poisson
distribution (squares) [19]. The slope of the linear regression through the
experimental data is virtually identical to that of the Poisson distribution data,
indicating that the reduction in intrasample precision seen below 500 pg of total
RNA is entirely due to dilution effects, rather than a limitation of BIIB. (C)
Intersample precision. Average adjusted expression intensities are plotted as a
function of starting mass of total RNA. Eight probe sets representing
housekeeping genes at various relative expression intensities were chosen for
visualization: GAPD (⋄), RPL13A (▵), ACTB (x), HPRT1 (—), YWHAZ (+),
TFRC (□), HMBS (*), and PCX (○). A linear regression yields slope and R2
values close to the ideal value of 1. Using all 22,626 probe sets, slope and R2
values were found to average 1.03 ± 0.14 and 0.96 ± 0.05, respectively. A
similar calculation, considering only the highest expressing 11,313 probe sets,
found slope and R2 values to average 1.02 ± 0.11 and 0.99 ± 0.03, respectively.AFFX 1rd. So while AFFX 1rd clearly outperforms BIIB with
regard to intrasample precision, BIIB produces data with
relatively high reproducibility.
A directly trending increase in CVoccurs for 100-, 50-, and
10-pg samples, resulting in CVs of 7, 11, and 17% at an intensity
of 3.4. Since a single cell typically contains 10 pg of total RNA
and on average only 10–15molecules of eachmRNA species are
present per cell, we speculated that the reduced precision was
due to stochastic variation introduced by the dilution [17,18].
Using a Poisson distribution model, Stenman et al. have demon-
strated that sampling error can dominate technical and metho-
dological inaccuracy as transcript copy number approaches
unity [19]. They have reported that at 1000, 200, 40, and
8 theoretical copies, the actual copy number in a highly diluted
solution can deviate by as much as 6, 14, 30, and 62%, res-
pectively, simply due to stochastic effects. Each sample in the
precision analysis described above contained the B. subtilis
transcripts dap, thr, phe, and lys at constant molar complexity
Fig. 4. BIIB accuracy and linear limit of detection using exogenous control
transcripts. A mass titration of dap, thr, phe, and lys transcripts was spiked at
equal molar ratios relative to four replicate samples of 5 ng (□), 1 ng (⋄), 0.5 ng
(▵), 100 pg (○), or 50 pg (×) mouse universal total RNA. Adjusted intensities
were converted to log values, and replicates were averaged. A linear regression
of adjusted intensity versus absolute mass of spiked transcript produces a slope
of 1.02 and R2 of 0.99. Arrow denotes the linear limit of detection at 0.02 fg,
corresponding to 20 absolute copies.
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On a molecular basis, the 500-pg total RNA sample, represent-
ing a 1:10,000 dilution of the stock solution, contained 1370,
365, 183, and 91.6 copies of dap, thr, phe, and lys, respectively.
Similarly, 10 pg of total RNA, representing a 1:500,000 dilution
of the stock solution, contained 27.4, 7.3, 3.7, and 1.8 copies of
the spikes. The CV for each spike present between 1000 and
8 copies for starting total RNA mass at and below 500 pg was
extracted from Fig. 3A (dotted vertical lines). These CV values
were plotted versus spike copy number and alongside the
Poisson distribution data (Fig. 3B). Notably, a linear regression
through our data yielded an R2 of 0.97, suggesting that precision
is correlated directly with copy number. In addition, the slope of
this linear regression is virtually identical to that of the Poisson
distribution data. Taking the data altogether, we conclude that
the reduction in precision seen below 500 pg of total RNA is the
manifestation of the stochastic variance inherent in working with
highly diluted samples of limiting amounts of material, rather
than a gross limitation of BIIB. The ability of BIIB to detect
stochastic variance also speaks to the sensitivity, which will be
investigated in more detail below.
Intersample precision was quantitatively determined by first
calculating adjusted intensity, a measurement obtained by
dividing the expression intensity for each probe set in a sample
by a dilution factor. For 5-ng, 1-ng, 0.5-ng, 100-pg, or 50-pg
samples, the dilution factor equaled 1, 5, 10, 50, or 100, res-
pectively. Adjusted intensities were converted to log values and
replicates were averaged. Data for 10 pg of startingmaterial were
not included in our analysis of intersample precision because of
the dramatic decrease in present calls (Fig. 1B), a significant
increase in scaling factor (data not shown), and the strong
influence of stochastic variation for this dilution point. A linear
regression of adjusted intensity as a function of starting mass of
total RNA for each probe set should capitulate slope and R2
values of 1 if perfect intersample precision is maintained.
Deviation from the unity values would indicate a bias inherent in
the BIIB process. Using all 22,626 probe sets, slope and R2
values were found to average 1.03 ± 0.14 and 0.96 ± 0.05,
respectively. A similar calculation, considering only the highest
expressing 11,313 probe sets, found slope and R2 values to
average 1.02 ± 0.11 and 0.99 ± 0.03, respectively. Taken
together, these data indicate virtually no bias when working
within a range of 5 ng to 50 pg of starting material. This linearity
was maintained despite the stochastic effects found in our
intraprecision analysis, highlighting the ability of replicates to
overcome transcript sampling errors caused by the dilution.
Eight probe sets representing housekeeping genes across a
diverse range of relative expression intensities were chosen for
visualization of BIIB intersample precision (Fig. 3C).
Accuracy and sensitivity of BIIB using exogenous transcripts
Each sample in the precision analysis described above con-
tained B. subtilis transcripts dap, thr, phe, and lys at a molar
complexity ratio, relative to the amount of mRNA in the total
RNA sample, of 1:6666, 1:25,000, 1:50,000, and 1:100,000,
respectively. On a mass basis, the 5-ng total RNA samplecontained 15, 4, 2, and 1 fg of dap, thr, phe, and lys, respectively.
Similarly, the 50-pg total RNA sample contained 150, 40, 20,
and 10 ag of dap, thr, phe, and lys, respectively. In this manner,
we generated a data set of expression intensity values for
overlapping, known masses of exogenously spiked transcripts.
Next, using the adjusted intensity values described in our inter-
sample precision analysis, we plotted spike intensity as a
function of transcript mass (Fig. 4). A linear regression through
these data yielded a slope of 1.02 and R2 of 0.99, almost
matching the unity values expected from a perfectly accurate
assay. Remarkably, this accuracy is maintained despite utilizing
single-channel intensity data from four different probe sets
spiked into varying quantities of starting total RNA. The 10-ag
dap spike from 50 pg of total RNA sample was excluded from
this analysis because at or below this value the exogenous
transcripts do not behave in a linear manner, despite being
detected above the background signal. Therefore, we define the
linear limit of detection of BIIB to be 20 ag or, on a molecular
basis, about 20 absolute copies.
Accuracy of BIIB using QRT-PCR and a total RNA tissue panel
While the relative expression intensities of exogenous
transcripts indicated a noteworthy level of accuracy, we felt
that additional validation of an alternative sample RNA set via a
complementary technology was prudent to certify the results.
Eight housekeeping genes were identified in themouse universal
total RNA as present across a 3-log range of relative expression
(Fig. 3C). QRT-PCR primer sets were designed to the Affy-
metrix probe set consensus sequence and the relative expression
for each transcript was determined across an eight-tissue total
RNA panel. Similarly, 1 μg or 500 pg of total RNA was sub-
jected to AFFX 1rd or BIIB, respectively, and hybridized toMG-
430A GeneChips. Five hundred picograms was chosen as input
for BIIB because it resided squarely in the center of the
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presented above. For each housekeeper, 28 pair-wise expression
ratios were created from the tissue panel, resulting in a data set of
224 unique ratios for each technology.
AFFX 1rd and BIIB ratios were each compared to QRT-PCR
data. The AFFX 1rd protocol gave an R2 value of 0.86, using a
linear regression of the logged data (Fig. 5A). Similarly, BIIB
demonstrated a high degree of correlation with QRT-PCR data
with a R2 value of 0.81 (Fig. 5B). While these data suggest
slightly better performance byAFFX 1rd, we consider this minor
concordance decrease to be acceptable in light of the extra
processing experienced by the BIIB samples. In addition, the
BIIB data are derived from only 500 pg of total RNA, a 2000-
fold reduction from the amount used in AFFX 1rd. At this RNA
level, we have demonstrated that stochastic sampling error can
influence transcript representation and could therefore adversely
affect R2 measurement. We also observed no apparent trend
between the accuracy of an mRNA ratio measurement and the
relative abundance across tissues, providing additional evidence
that the actual transcript level is not skewed during the
amplification process.Fig. 5. Accuracy of BIIB by QRT-PCR validation using a total RNA tissue
panel. QRT-PCR primer sets were designed using the Affymetrix probe set
consensus sequence of eight housekeeping genes: GAPD (⋄), RPL13A (▵),
ACTB (x), HPRT1 (—), YWHAZ (+), TFRC (□), HMBS (*), and PCX (○).
1 μg or 500 pg of total RNA from mouse brain, embryo, heart, kidney, liver,
lung, ovary, and spleen was processed using AFFX 1rd or BIIB, respectively.
For each probe set, 28 pair-wise tissue expression ratios were created. Results
from (A) AFFX 1rd and (B) BIIB are plotted against values obtained by
QRT-PCR.B- and T-cell-enriched genes identified using 100 flow-sorted
primary cells
To prove the applicability of the BIIB protocol to flow-sorted
cells, we stained a pool of primary lymphocytes isolated from a
single mouse spleen using B-cell- or T-cell-specific markers.
This sample was used to sort a titration of 100 total cells directly
into lysis buffer in duplicate. We chose 100 cells because
preliminary sorting experiments indicated a reduction in present
calls below this value (see Supplementary Fig. 3). Each sample
well received the following numbers of Tand B cells (T/B): 100/
0, 80/20, 60/40, 40/60, 20/80, or 0/100. The titration was
repeated for 500 total cells at identical T or B cell ratios.
Amplification of the 100-cell samples by BIIB yielded sufficient
cDNA for hybridization toMG-430 GeneChips and present calls
averaged 20.0 ± 3.5%. When a similar titration of 500 total cells
was attempted, present calls were 24.6 ± 4.7%. Despite a
fivefold increase in the number of cells, the overlapping standard
deviations indicate that present calls did not significantly
change.
Microarray Suite 5.0 (MAS 5.0) probe set intensities for
each hybridization were normalized using a rank-based
quantile method. We then used a rank-based quantitative trait
analysis within BRB-Array Tools, developed by Dr. Richard
Simon and Amy Peng of the National Cancer Institute. The
percentage of T cells in each sample was used as the trait. This
statistical test uses data from the 12 hybridizations to identify
probe sets that either correlate or anticorrelate with the
quantitative trait, thereby identifying T-cell-enriched or B-
cell-enriched transcripts. A highly stringent multivariate per-
mutation filter was applied to limit the number of false
positives to 0 at a 99% confidence interval. We also specified
that the log ratio of the 100% T cell versus 100% B cell profile
be less than −1 or greater than 1, corresponding to fold changes
of −10 and 10.
The resulting list contained 25 T-cell-specific and 31 B-cell-
specific transcripts, after duplicate qualifiers were removed. A
similar analysis conducted with 500 cells resulted in a list that
contained 32 T-cell- and 41 B-cell-specific qualifiers. The
union of these two lists yielded 51 T cell and 64 B cell qua-
lifiers, indicating little overlap between the two lists. However,
an expression intensity heat map of these qualifiers illustrates
the high degree of concordance between the 100- and the 500-
cell data, suggesting that the 99% confidence interval and 10-
fold change cut-off eliminated biologically relevant and
similarly performing qualifiers from both lists (see Supple-
mentary Fig. 4).
The majority of these qualifiers are known lymphocyte-
enriched transcripts, while a smaller proportion lack annotation
or have not been specifically described as associated with
immune-related functions. A subset of genes identified as T cell
enriched by profiling data contains known T cell markers, such
as CD3, CD8, CD27, and the T-cell receptor α and β chains, as
well as known B cell markers, including CD22, CD24, several
histocompatibility 2 class II family members, and many
immunoglobulin family members (Fig. 6). From this analysis,
BIIB displays the ability to capture an expression profile that
Fig. 6. B-cell- and T-cell-enriched genes identified using BIIB on 100 primary cells flow sorted from mouse spleen. 100 total cells (n = 2) or 500 total cells per
sample (n = 1) were sorted directly into lysis buffer. Using TCR and B220 marker staining, each sample well received a titration of T or B cells (columns), which
was subsequently purified and processed by BIIB. The heat map represents gene expression values for a subset of 51 T-cell- or 64 B-cell-specific qualifiers
identified by quantitative trait analysis. False coloring is on a global basis with red, black, and green representing relatively high, mid, and low expression,
respectively. Results are consistent across the 100- and 500-cell titration. This list contains the known T cell markers CD3, CD8, CD27, and the T cell receptor α
and β chains (top), as well as the known B cell markers CD22, CD24, several histocompatibility 2 class II family members, and many immunoglobulin family
members (bottom).
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as 100 primary flow-sorted cells.
Discussion
Our initial aim was to validate technically an amplification
and labeling strategy compatible with Affymetrix GeneChips
that would be used as a core service standard operating pro-
cedure for all experiments in which the quantity of total RNA
was limiting. Commercially available kits advertise compatibil-
ity only to 5 ng of total RNA, a value significantly above the
sensitivity required for many prospective experiments. These
sample size requirements ultimately led us to develop our own
protocol, designated BIIB.
While being loosely based on AFFX 2rd, BIIB uses reduced
volumes for first- and second-strand synthesis to drive equi-
librium to favor limited quantities of sample, eliminates puri-
fication of the second-strand product to reduce sample loss due
to column inefficiencies, and generates a second-round in vitro
transcription (IVT) product that is not labored by modifiednucleotide incorporation. We were also intrigued by the cDNA
target generated in the NGN kit, which allowed for hybridiza-
tions using only 2 μg of material. Therefore, BIIB also uses an
antisense cDNA target created from the second-round cRNA,
through randomly primed first-strand synthesis followed by
Klenow labeling using biotin-14–dCTP. This step adds an
additional day of sample processing, resulting in a total of
3.5 days to complete the BIIB method. Fragmentation was not
performed, since gel analysis revealed the cDNA target ranged
between 50 and 700 bp in length, with the majority less than
200 bp (data not shown) [20].
Based on preliminary benchmarking experiments, the sum of
these considerations reduced the total RNA requirement for
>50% present calls to 100 pg, while also improving upon the
gene expression accuracy of the AFFX 2rd, NGN, and ARC kits
(Figs. 1B and 1D). Further analysis of intersample precision
suggests as much as 100-fold improvement, allowing for a full,
unbiased expression profile within a range of 5 ng to 50 pg of
starting total RNA (Fig. 3C). This represents a 40- to 200-fold
improvement over the commercially available kits and the most
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Intrasample precision studies were consistent with the above
data and showed BIIB to generate highly reproducible
expression values at 50 pg of starting total RNA mass, once
the stochastic effects of dilution are considered (Figs. 3A and
3B). To our knowledge, this is the first validated report of any
microarray experiment sensitive enough to detect stochastic
events inherent in the sample source.
A more detailed investigation of accuracy and sensitivity,
using the expression intensities of exogenous transcripts,
showed BIIB to represent the original total RNA pool with
near-perfect linearity to a limit of 20 absolute copies (Fig. 4). In a
GeneChip experiment using single neuronal progenitor cells,
Tietjen et al. were able to detect reproducibly 10 absolute copies
of spiked transcripts identical to those used in our study [3]. By
this common measure, BIIB is performing equivalent to one of
the most sensitive methodologies to date, without the need to
employ 80 cycles of PCR, which has been shown to introduce
sequence-, length-, and abundance-dependent transcript biases
[2,4–7]. Our linear limit of detection is also consistent with the
high level of present calls observed when using 50 pg of starting
material (Fig. 1B), assuming that a single cell contains 10 pg of
total RNA and on average has 10–15 molecules of each mRNA
species [17,18]. Therefore, in 50 pg of total RNA we would
expect 50–75 copies of most RNA species, an abundance level
within our assay sensitivity limit of 20 copies.
Finally, BIIB accuracy was confirmed using expression ratio
measurements validated by QRT-PCR (Fig. 5). Several publi-
cations concerning RNA amplification have compared ratio
data of unamplified and amplified probes hybridized to micro-
arrays. In these studies, linear and exponential amplification
protocols from nanogram quantities of total RNA have shown
an average R2 of 0.76 and 0.62, respectively [2,7,11,13]. Goff et
al. have compared transcript levels of 48 genes for six different
amplification strategies on either rat liver or rat brain total RNA
using QRT-PCR [10]. Their expression ratio plots yield R2
values ranging from 0.64 to 0.81 depending on the amplifica-
tion protocol employed. Our QRT-PCR ratio data verify that,
even from picogram quantities of material, BIIB exceeds the
accuracy of similar multiround linear and PCR-based amplifi-
cation methods.
Many of the improvements described above can be attributed
to the use of a Klenow-synthesized cDNA probe, which results
in a 5-fold reduction in the cRNA necessary for hybridization.
We found that 2 μg of cRNA typically yields 6 μg of cDNA
product, indicating that the strand displacement activity of
Klenow results in a 2-fold amplification of the antisense strand
(data not shown). Similar work, published during the prepa-
ration of this article, showed that Klenow labeling with Cy-dye-
modified nucleotides amplified 1 μg of cRNA product 5-fold
[13]. This amplification partly explains why only 2 μg of cRNA
is required for hybridization of a biotinylated cDNA target
compared to 11 μg for a biotinylated cRNA target. Further
signal enhancement could be attributed to modified nucleotide
labeling disparities, by which Klenow is reported to incorporate
eight biotin molecules per 100 bp, while the Affymetrix IVT
labeling kit assimilates only six [20,21]. Additionally, we ob-served that the BIIB cDNA target hybridization background
values were consistently 2.5-fold lower than those of cRNA
hybridizations from equivalent sources, significantly improving
signal to noise. Finally, there is some evidence to suggest that
using a cDNA probe might reduce the intensity value of Gene-
Chip mismatch probes [22]. This could ultimately explain both
sensitivity and accuracy improvements, but further investi-
gation of the phenomenon remains beyond the scope of this
project.
Clearly, the use of a cDNA target accounts for only a portion
of the improved performance, indicating that adjustments made
to the first- and second-round enzymatic reactions must be of
vital importance. Interestingly, reduction of enzymatic reaction
volumes and elimination of purification steps did not signi-
ficantly increase the absolute yield of cRNA (data not shown).
Rather, these modifications, likely in synergy with the use of a
cDNA probe, appear to have reduced nonspecific nucleic acid
synthesis in the cRNA product. For example, using either
AFFX 2rd or BIIB on 500 pg of total RNA produces sufficient
cRNA for hybridization (Fig. 1A). Yet, present calls for BIIB
averaged 54%, while AFFX 2rd present calls were reduced to
40%. These data would suggest that AFFX 2rd produces a
significant and consistent amount of nonspecific cRNA pro-
duct, which accounts for a larger proportion of total cRNA
yield as the original sample size decreases, eventually reaching
a level that adversely influences present calls. By scaling down
all components of the second-round enzymatic reactions we
have increased the concentration of the transcript pool relative to
primers and thus increased the chances of specific amplification
events. Specificity improvements of BIIB could also be the
result of a second-round IVT that is no longer burdened by
modified nucleotide incorporation. Eliminating the steric effect
of biotin reduces the accumulation of truncated cRNA product
due to early polymerase termination and improves cRNA syn-
thesis through difficult secondary structure. Superior perfor-
mance of BIIB in target degradation and expression level
accuracy plots provides some evidence that this may be the case
(Figs. 1C and 1D).
In our experience, upstream technologies that gather small
quantities of ribonucleic acid often reduce the fidelity of the
transcript pool. In the case of LCM, harsh sample processing
experienced during mounting, staining, and capture can result in
poor quality RNA. Similarly, the time necessary to sacrifice an
animal, isolate the target tissue, remove tissue debris, stain for
surface markers, and sort rare cell populations can significantly
degrade RNA. Like all the commercial kits evaluated here, BIIB
uses a primer that targets the 3′ end of a transcript. Therefore,
BIIB is not capable of producing a high-quality GeneChip target
when starting from samples with compromised RNA integrity.
Compounding this issue, when only picogram quantities of input
RNA are available, we have yet to discover a reliable means of
assaying RNA quality and quantity without consuming almost
all of the sample. Perhaps a QRT-PCR approach, utilizing
several probes tiled across the length of housekeeping tran-
scripts, may be able to elucidate this information prior to
GeneChip target synthesis. Although we have shown that BIIB
improves upon current RNA quantity requirements, sample
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RNA integrity is minimized. A variation of our protocol,
substituting a T7 promoter linked to random oligonucleotides as
the primer for first strand synthesis, might be able to overcome
the current incompatibility of these methods in situations that
yield poor quality RNA.
The ultimate utility of the BIIB protocol has been success-
fully illustrated using surface marker staining, flow sorting,
amplification, labeling, and hybridization of a 100- and 500-cell
titration of primary lymphocytes. These experiments have
reproducibly and accurately identified transcripts for known
markers of B and T cell lineages (Fig. 6), as well as many
unannotated transcripts that could potentially harbor important
immune-specific functionality (see Supplementary Fig. 4). We
have also had success in ongoing experiments profiling rare
peripheral lymphocyte subpopulations sorted using multiple
surface markers. By using only 100 cells, a single animal can be
sacrificed, sorting times take seconds rather than hours, and
direct sorting into lysis buffer is possible. Thereby, BIIB has the
distinct ability to capture animal-specific biology of rare cell
populations, while minimizing the time requirements of sample
processing, during which the transcriptional state of the cells
may change or RNA integrity may be compromised.
We observed reduced present calls in the B and T cell
populations (20–25%) compared to the mouse universal sample
used in development experiments (44–54%, Fig. 1B) or 100
cells from a macrophage cell line (44%, see Supplementary Fig.
3). This is not altogether surprising, given that the lymphocyte
samples were composed of two pure, nonactivated, primary cell
types versus the diverse transcript population of the pooled
sample or increased transcript activity of an immortalized cell
line. Other studies have reported that homogeneous subpopula-
tions of cells often yield present calls lower than would be
expected from their complex tissue counterparts [6,23]. Simi-
larly, in data not presented here, we have observed lower
present calls in LCM large motor neurons (44%) and adjacent
tissue (31%), compared to the heterogeneous source (55%).
These data underscore the importance of reducing tissue
complexity to reveal the composite expression profiles that
would otherwise be obscured in a heterogeneous sample.Materials and methods
Total RNA sample preparation
Universal Reference RNA representing a pool of 11 different mouse cell
lines was purchased from Stratagene (La Jolla, CA, USA). Embryo, embryo
(fibroblast), kidney, liver (hepatocyte), lung (alveolar macrophage), B
lymphocyte, T lymphocyte, mammary gland, muscle myoblast, skin, and testis
cell lines are represented. Total RNA was further cleaned using the Pico Pure
RNA Isolation Kit (Arcturus, Mountain View, CA, USA) with optional on-
column DNase treatment with the RNase-Free DNase Set (Qiagen, Valencia,
CA, USA). A stock solution was used as the starting source for serial dilutions
according to the Affymetrix Eukaryotic Sample Analysis Technical Manual,
revision 5. In brief, B. subtilis transcripts lys, phe, thr, and dap from the
Eukaryotic Poly-A Control Kit (Affymetrix) were spiked into 5 μg of mouse
universal total RNA at a complexity ratio of 1:100,000, 1:50,000, 1:25,000, and
1:6666, respectively. Strictly in terms of mass, every 3 μl of stock solution
contained 5 μg of mouse universal RNA, 15 pg of dap, 4 pg of thr, 2 pg of phe,and 1 pg of lys. Mass to copy number conversions were determined assuming
an average transcript length of 2000 bp, a molecular weight of 330 g/mol/bp,
and 2% mRNA component of total RNA. A replicate is defined as a separate
serial dilution series from the stock solution, as well as a separate master mix
for all enzymatic reactions. The Mouse Assorted Total RNA Kit (Ambion,
Austin, TX, USA) was used in QRT-PCR validation experiments. Liver,
brain, heart, lung, spleen, ovary, kidney, and embryo derived from Swiss
Webster mice are represented. Total RNA samples were further cleaned using
the RNeasy Kit (Qiagen). Isolation and purification of total RNA for flow-
sorting experiments were conducted using the RNAqueous-Micro Kit
(Ambion) with substitution of DEPC-treated water for nucleic acid elution
in the final step.
Lymphocyte flow sorting
A cell suspension was made after physical disruption of a spleen excised
from a single mouse. The cell suspension was treated with ammonium
chloride lysis buffer (0.15 M NH4Cl, 0.1 M KHCO3, 0.01 mM EDTA) to
deplete the erythrocytes. The resulting debris was strained and the cells were
washed. Following incubation with purified anti-FcγRII/FcγRIII to block the
Fc receptors, the cells were stained for 30 min at 4°C with FITC-conjugated
anti-B220, clone RA3-6B2, and PE-conjugated anti-TCR-β chain, clone H57-
597 (BD PharMingen, San Diego, CA, USA). A MoFlo Cell Sorter
(DakoCytomation, Ft. Collins, CO, USA) was then used to perform the cell
isolation. In brief, the lymphocyte population was identified using forward
and side scatter measurements. Nonaggregated single cells within this popu-
lation were gated by forward scatter height and pulse-width measurements.
Finally, variable numbers of B and T cells were individually sorted into a 96-
well plate containing 150 μl of lysis buffer by gating on either B220 or TCR-
β markers.
Amplification and labeling of total RNA for Affymetrix GeneChips
GeneChip One-Cycle Target Labeling and Control Reagents (Affymetrix)
and the recommended protocols from the Affymetrix Eukaryotic Sample
Analysis Technical Manual, revision 5 (Affymetrix SOP) were utilized on four
replicates of a 1-μg dilution of mouse universal total RNA stock solution.
Similarly, 1 μg of total RNA from liver, brain, heart, lung, spleen, ovary, kidney,
and embryo was processed. This protocol, referred to as AFFX 1rd, involves a
single round of IVT resulting in a biotinylated cRNA target. GeneChip Two-
Cycle Target Labeling and Control Reagents (Affymetrix) and Affymetrix SOP
were utilized on two replicates of 500-ng, 50-ng, 5-ng, 0.5-ng, and 50-pg
dilutions of mouse universal stock solution using 20 ng/μl poly(I) (Sigma, St.
Louis, MO, USA) as a carrier nucleic acid. This protocol, referred to as AFFX
2rd, involves two rounds of in vitro transcription resulting in a biotinylated
cRNA target. The RiboAmp HS RNA Amplification Kit (Arcturus) and
recommended protocols from laboratory manual version C were utilized on two
replicates of 500-ng, 50-ng, 5-ng, 0.5-ng, and 50-pg dilutions of mouse
universal stock solution using 20 ng/μl poly(I) (Sigma) as a carrier nucleic acid.
This protocol, referred to as ARC HS, involves two rounds of in vitro
transcription resulting in a biotinylated cRNA target. The NuGEN Ovation
Biotin–RNA Amplification and Labeling System, version 1.0 (NuGEN, San
Carlos, CA, USA) was utilized according to recommended protocols on two
replicates of 500-ng, 50-ng, 5-ng, 0.5-ng, and 50-pg dilutions of mouse
universal stock solution. This protocol, referred to as NGN, involves a single-
round, linear amplification procedure utilizing a DNA/RNA chimeric primer
and DNA polymerase to generate a biotinylated cDNA target. The amplification
procedure that we have developed and validated in this article, referred to as
BIIB, comprises two rounds of in vitro transcription, followed by a randomly
primed first-strand cDNA reaction. Klenow fragment of DNA polymerase I is
then used in a second-strand synthesis to create a biotinylated cDNA probe [24].
BIIB was utilized on four replicates at 5-ng, 1-ng, 0.5-ng, 100-pg, 50-pg, and 10-
pg dilutions of mouse universal stock solution. Single samples using 500 pg of
total RNA from liver, brain, heart, lung, spleen, ovary, kidney, and embryo were
also processed using BIIB. Similarly, BIIB was used on 12 samples containing
the total RNA purified from 100 primary cells and 6 total RNA samples purified
from 500 primary cells.
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Unless otherwise noted, reagents from the GeneChip Two-Cycle cDNA
Synthesis Kit (Affymetrix) were utilized. Alternatively, enzymatic reagents
(Invitrogen Corp., Carlsbad, CA, USA) may be substituted. The total cost per
amplification and labeling using BIIB is about $110 US. All enzymatic reactions
with the exception of the final Klenow labeling were carried out in a 96-well MJ
Research thermocycler (Bio-Rad Laboratories, Hercules, CA, USA).
Day 1, IVT round 1
Total RNA suspended in 3 μl of DEPC-treated water was supplemented with
2 μl of 5 μM T7-Oligo(dT) primer, heated to 70°C for 6 min, and cooled to 4°C.
First-strand master solution containing 2 μl of 5× 1st Strand Rxn Mix, 1 μl of
0.1 M DTT, 0.5 μl of 10 mM dNTP, 0.5 μl of RNase inhibitor, and 1 μl of
SuperScript II enzyme was added to the total RNA, then incubated for 1 h at
42°C, followed by 10 min at 70°C, and finally cooled to 4°C. Second-strand
master mix containing 4.8 μl of DEPC-treated water, 4.0 μl of 17.5 mMMgCl2,
0.4 μl of 10 mM dNTP, 0.6 μl of Escherichia coli DNA polymerase I, and 0.2 μl
of RNase H was added to the first-strand reaction, incubated for 2 h at 16°C with
the thermocycler heated lid disabled, heated to 75°C for 10 min, and cooled to
4°C. The MEGAscript T7 kit (Ambion) was used to assemble the IVT master
mix containing 5 μl each of 10× reaction buffer, enzyme mix, and ATP, CTP,
UTP, and GTP solutions. This solution was added directly to the product of the
second-strand reaction and incubated for 16 h at 37°C.
Day 2, IVT round 2
IVT product was purified using cRNA Cleanup Spin Columns and protocols
found in the Affymetrix Sample Cleanup Module. Purification was conducted
according to Affymetrix SOP, with the exception of elution, which used 20 μl of
DEPC-treated water.When starting with 50 ng of total RNA, the concentration of
cRNA sample was determined and a 300-ng aliquot removed for further proces-
sing. The volume of cRNA product was reduced to 4 μl by vacuum centrifuga-
tion, supplemented with 1 μl of 0.2 μg/μl random primers, heated to 70°C for
6min, and cooled to 4°C. First-strandmaster solutionwas formulated and added to
the purified cRNA as described for IVT round 1. First-strand reaction was incu-
bated at 42°C for 1 h, followedby addition of 0.5μl RNaseH prior to incubation for
20 min at 37°C, and finally enzyme inactivation at 95°C for 5 min. Next, 2 μl of
5 μM T7-Oligo(dT) primer was added to the first-strand reaction. The solution
was denatured at 70°C for 6 min and cooled to 4°C. Second-strand master mix
containing 2.5 μl of DEPC-treated water, 4.0 μl of 17.5 mM MgCl2, 0.4 μl of
10 mM dNTP, and 0.6 μl of E. coli DNA polymerase I was added to the first-
strand reaction and incubated for 2 h at 16°C with the thermocycler heated lid
disabled.Next, 0.5μl of T4DNApolymerasewas added. Incubation proceeded at
16°C with the thermocycler heated lid disabled, followed by inactivation at 75°C
for 10 min before cooling to 4°C. Second-round IVTmaster mix was prepared as
above, added directly to the product of the second-strand reaction, and incubated
for 16 h at 37°C.
Day 3, Klenow labeling
The IVTproductwas cleaned as described above,with the exception of elution,
which was carried out using 50 μl of DEPC-treated water. The concentration of
cRNAwas determined. A 2-μg aliquot of cRNAwas removed, vacuum centri-
fuged to 8 μl, and used as the template for cDNA production via the SuperScript
III First-Strand Synthesis System for RT-PCR (Invitrogen). cRNA was supple-
mented with 1 μl of dNTP mix and 1 μl of random hexamers, denatured at 65°C
for 5 min, and cooled at 4°C. First-strand master solution containing 2 μl of 10×
RT buffer, 4 μl of 25 mMMgCl2, 2 μl of 0.1MDTT, 1 μl of RNaseOUT, and 1 μl
of SuperScript III enzymewas added to cRNA. Themixturewas then incubated at
25°C for 10 min, 42°C for 50 min, and 85°C for 5 min and finally cooled to 4°C.
cRNA template was degraded by adding 1 μl of RNase H and incubating at 37°C
for 20 min. Second-strand synthesis was completed via the BioPrime DNA
Labeling System (Invitrogen). The entire first-strand reaction was combinedwith
100 μl of the 2.5× random primers solution and 29 μl of water. The sample was
then heated to 95°C for 5 min followed by 5 min of chilling at 4°C. A master mix
containing 25 μl of 10× dNTP mixture (1 mM biotin-14–dCTP, 2 mM dATP,
2 mM dGTP, and 2 mM dTTP), 70 μl of water, and 5 μl of Klenow fragment was
added to the first-strand solution and incubated at 37°C for 2 h. Finally, 25 μl of
Stop buffer was added to each sample and frozen at −20°C overnight.Day 4, second-strand purification
The second-strand reaction was transferred to a 15-ml conical tube
containing 2.5 ml of buffer PN from the QIAquick Nucleotide Removal Kit
(Qiagen). Successive 750-μl aliquots of cDNA/PN solution were added to a
QIAquick column using a QIAvac 24 vacuum manifold (Qiagen). Column-
bound cDNA was washed with 1 ml of buffer PE, dried completely using
centrifugation at 12,000 RCF for 5 min, and finally eluted in 70 μl of H2O.
Target hybridization to Affymetrix GeneChips
Procedures that generated cRNA targets, AFFX 1rd, AFFX 2rd, and ARC
HS, were fragmented according to the Affymetrix SOP using volumes scaled to
accommodate 11 μg of input target RNA. If less than 11 μg was generated then
the entire cRNA product was used as input. cDNA from the NGN procedure was
fragmented and biotin labeled according to NuGEN recommendations to yield
2.2 μg of cDNA target. If less than 2.2 μg was generated then the entire cDNA
product was used as input. The entire Klenow reaction product, generated from a
2-μg aliquot of cRNA, was used as the BIIB cDNA target. All samples were
hybridized according to Affymetrix SOP. In brief, cDNA and cRNA targets were
suspended in a final volume of 220 μl of 1× hybridization buffer supplemented
with 0.5 mg/ml acetylated BSA, 0.1 mg/ml herring sperm DNA, control oligo
B2, eukaryotic control transcripts, and 10% DMSO. Two hundred microliters of
each sample was hybridized overnight at 45°C to a Mouse Genome 430A
GeneChip. Samples were washed and stained on a GeneChip Fluidics Station
450 using the EukGE-WS2v4 script and visualized using a GeneChip Scanner
3000. For all samples, the statistical algorithm of MAS 5.0 was used to calculate
probe set expression intensities with a scaling factor of 2500 and served as the
starting point for further analysis.
QRT-PCR experiments
Oligonucleotide primers (Biosearch Technologies, Novato, CA, USA) and
TaqMan MGB (Applied Biosystems, Foster City, CA, USA) probes were de-
signed using Primer Express version 2.0.0 (Applied Biosystems) from the
Affymetrix consensus sequence for the following housekeeper probe sets:
1436722_a_at (β-actin, ACTB), 1418625_s_at (glyceraldehyde-3-phosphate
dehydrogenase, GAPD), 1426475_at (hydroxymethylbilane synthase, HMBS),
1448736_a_at (hypoxanthine guanine phosphoribosyl transferase 1, HPRT1),
1416383_a_at (pyruvate carboxylase, PCX), 1455485_x_at (ribosomal protein
L13a, RPL13A), 1452661_at (transferrin receptor, TFRC), and 1448218_s_at
(tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, ζ,
YWHAZ). TaqMan MGB probes contain a 5′ covalently linked fluorescent
reporter dye (FAM) and a minor groove-binder nonfluorescent quencher
(MGBNF) covalently linked to the 3′ end. Oligonucleotide standard template
(Biosearch Technologies) design included 10 bp of gene-specific sequence at the
5′ and 3′ ends of the amplicon. Total RNA samples were concentration normal-
ized by measuring absorbance at 260 nm. Residual DNAwas removed from 5 μg
of total RNA using 5 units DNase I amplification grade (Invitrogen) at 20°C for
15 min. An aliquot of the treated sample was used as control in subsequent QRT-
PCR assays to ensure the absence of DNA contamination. The remainingDNase-
treated RNAwas used in a cDNA synthesis reaction using a high-capacity cDNA
archive kit (Applied Biosystems). Oligonucleotide templates were pooled and
then serially diluted 1:10 eight times in 25 ng/μl yeast RNA (Ambion) to include a
final range 500 fM to 5 zM. Quadruplicate PCRs for samples and standards were
mixed in a 96-well plate and then transferred to a 384-well optical plate (Applied
Biosystems) and cycled in a 7900HT (Applied Biosystems) thermocycler under
the following conditions: 50°C for 2 min (uracil N-deglycosylase digest), 95°C
for 10min (activation of Taq thermostable polymerase), and 40 cycles of 95°C for
15 s and 60°C for 60 s. Relative transcript quantity for each sample was
determined by comparison to an oligonucleotide standard curve using Sequence
Detection software (Applied Biosystems).
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